Rhea Coler, MSc, PhD
Professor Senior Investigator, Center for Global Infectious Disease Research (CGIDR) Adjunct Professor, Department of Global Health
Dr. Coler has focused on four main multi-disciplinary areas: 1) Advancing tuberculosis (TB) vaccine and host-directed therapy platforms and models, 2) Blood processing and clinical immunology secondary endpoint and exploratory assays for NIH, VTEU, IDCRC and Biotech-funded trials to evaluate vaccines against SARS-CoV-2 and Mycobacterium tuberculosis 3) Nontuberculous mycobacteria vaccine development and 4) Mycobacteriophages therapy to kill superbugs.
Dr. Coler’s research has contributed to the invention of the M72/AS01e and ID93+GLA-SE – lead TB vaccine candidates. Dr. Coler’s clinical trials include prophylactic and therapeutic vaccines for a variety of infectious diseases including TB, COVID-19, influenza, and schistosomiasis.
Dr. Coler is passionate about training the next generation of researchers, and promoting awareness about Diversity, Equity, and Inclusion.